Board Meetings for KREBSBIO
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| KREBSBIO | Krebs Biochemicals and Industries Limited | 20 May 2019 | Financial Results | To consider and approve the financial results for the period ended March 31, 2019 | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 25 Mar 2019 | Other business matters | To consider and approve the allotment of shares subject to the approval of basis of allotment by the Stock Exchanges. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 12 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 11 Jan 2019 | Other business matters | To consider other business matters | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 30 Oct 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 30 Jul 2018 | Other business matters | Pursuant to Regulation 30 of SEBI (LODR) Regulations, we wish to inform you that in addition to the items of business to be considered and approved as mentioned in the notice of board meeting dated 23rd July 2018, the Board also to consider the following:- To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis (Rights Issue) to the shareholders of the Company. Kindly note that the closure of trading window for dealing in shares of the Company has already been effective for the specified persons as defined in the Code of conduct from 23rd July 2018 to 1st August 2018. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 30 Jul 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and approve the draft notice of 26th AGM along with the Board's report and annexures thereto and other business matters.Further, in connection to the above, trading window for dealing in shares of the Company will remain closed for the specified persons as defined in the Code from 23rd July 2018 and shall re-open 48 hours after the publication of results to the public. This is for the information & records of the Exchange, Please. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 25 May 2018 | Financial Results | To consider and approve the financial results for the period ended March 31, 2018 | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 13 Feb 2018 | Results/Others | To transact, inter alia the following: 1. To consider and approve the unaudited financial results along with the Limited Review Report for the quarter ended December 31, 2017. 2. Any other matter with the permission of the Chair. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 13 Nov 2017 | Results/Others | To transact, inter alia the following: 1. To consider and approve the unaudited financial results along with the Limited Review Report for the quarter and half year ended September 30, 2017. 2. Any other matter with the permission of the Chair. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 10 Aug 2017 | Results/Others | To transact, inter alia the following: (1) To consider and approve the unaudited financial results along with the Limited Review Report for the quarter ended June 30, 2017. (2.) To consider and approve the notice of the Annual General Meeting of the members along with Directors Report and annexures thereto. (3). Any other matter with the permission of the Chair. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 26 May 2017 | Results/Others | To transact, inter alia the following: 1. To consider and approve the audited financial results along with the auditor s report for the year ended March 31, 2017. 2. Any other matter with the permission of the Chair. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 09 Feb 2017 | Results/Others | to transact, inter alia the following: 1) To consider and approve the unaudited financial results for the quarter ended December 31, 2016. 2) Any other matter with the permission of the Chair. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 07 Dec 2016 | Results/Others | To transact, inter alia the following : (1) To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2016; (2) Any other matter with the permission of the Chair. | |
| KREBSBIO | Krebs Biochemicals and Industries Limited | 14 Sept 2016 | Results/Others | To transact, inter alia the following: 1. To consider and approve the unaudited financial results for the quarter ended June 30, 2016. 2. Any other matter with the permission of the Chair. |